XBiotech halts all rheumatology research after missing Phase II endpoints
The Texas-based company has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities.
BMS sees success in Phase III Sotyktu psoriatic arthritis trials
Most significant clincal trials of 2024
First patient dosed as Marengo’s invikafusp alfa trial expands to Europe
GSK’s combo therapy trial for advanced ovarian cancer meets primary endpoint
JCR Pharmaceuticals doses first patient in paediatric growth hormone trial
Analysis
View More
Themes
View MoreFirst blood-stage malaria vaccine ‘a much-needed addition’ – analyst
Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
APAC leading in Parkinson’s disease clinical trials
CEPI funds safety project for vaccines in Africa
myTomorrows adds ISRCTN to clinical trial search
Generative AI has ‘potential to revolutionise clinical development’